Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Lactobacillus Reuteri DSM 17938 to Evaluate Safety and Efficacy on Children With Mild or Moderate Atopic Dermatitis

NCT04265716 is registered in ClinicalTrials.gov with Innovacion y Desarrollo de Estrategias en Salud as lead sponsor.

NCT NCT04265716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04265716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Lactobacillus Reuteri DSM 17938 to Evaluate Safety and Efficacy on Children With Mild or Moderate Atopic Dermatitis
Lead sponsor
Innovacion y Desarrollo de Estrategias en Salud
Phase
Not applicable
Overall status
Unknown status
Start date
February 13, 2020
Completion date
October 30, 2020
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis